Sundrug Co Ltd

Common Name
Sundrug
Country
Japan
Sector
Healthcare
Industry
Pharmaceutical Retailers
Employees
7,145
Ticker
9989
Exchange
TOKYO STOCK EXCHANGE
Description
Sundrug Co., Ltd. is a prominent player in Japan's pharmaceutical and retail industry, operating a widespread network of drugstores and dispensing pharmacies. The company primarily focuses on providin...

Sundrug's Financial Statements Preview

Below are the financial statements of Sundrug, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of JPY
2024
2023
Net sales
751,777b
690,462b
Cost of sales
-562,457b
-518,516b
Gross profit
189,319b
171,946b
Selling, general and administrative expenses
Provision of allowance for doubtful accounts
-17b
-1b
Provision for retirement benefits for directors (and other officers)
-11b
-7b
Salaries, allowances and bonuses
-54,195b
-49,681b
Retirement benefit expenses
-638b
-638b
Rent expenses
-31,383b
-29,590b
Other
-62,075b
-54,574b
Total selling, general and administrative expenses
-148,323b
-134,493b
Operating profit
40,996b
37,452b
Non-operating income
Interest income
120b
119b
Dividend income
7b
6b
Commission income
91b
74b
Gain on receipt of donated non-current assets
350b
254b
Other
220b
270b
Total non-operating income
791b
725b
Non-operating expenses
Interest expenses
-32b
-36b
Provision of allowance for doubtful accounts
0b
-2b
Other
-26b
-4b
Total non-operating expenses
-59b
-43b
Ordinary profit
41,728b
38,134b
Extraordinary income
Gain on sale of non-current assets
21b
157b
Compensation income
4b
25b
State subsidy
429b
451b
Other
154b
26b
Total extraordinary income
610b
660b
Extraordinary losses
Cancellation penalty
0b
-123b
Loss on sale of non-current assets
0b
-13b
Loss on retirement of non-current assets
-133b
-108b
Loss on cancellation of rental contracts
-9b
-47b
Impairment losses
-481b
-542b
Loss on tax purpose reduction entry of non-current assets
-242b
-214b
Other
-211b
-35b
Total extraordinary losses
-1,078b
-1,084b
Profit before income taxes
41,261b
37,710b
Income taxes - current
-13,130b
-12,988b
Income taxes - deferred
-995b
-980b
Total income taxes
-12,134b
-12,007b
Profit
29,126b
25,703b
Profit attributable to non-controlling interests
0b
0b
Profit attributable to owners of parent
29,126b
25,703b
Download Data

Verified Sources Behind Sundrug’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sundrug’s data sources below and access millions more through our Disclosure Search.

a. Sundrug's Integrated Report 2025
a. Sundrug's Integrated Report 2025
b. Sundrug's Integrated Report 2024
b. Sundrug's Integrated Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?